The Consumer Technology Association and the Connected Health Initiative announced this morning a new multi-sector initiative of private tech companies, healthcare providers and representatives of public agencies that aims to outline technology's role in addressing health disparities exacerbated by COVID-19.
To this end, the effort's first major project will consist of a white paper containing...
On Friday the American Diabetes Association is set to kick of its annual scientific session in San Francisco. Diabetes focused organizations have already begun to make announcements ahead of the show. MobiHealthNews compiled a roundup of the diabetes-related news coming out this week.
GLOOKO, T1D TEAM UP
This morning, diabetes management platform Glooko announced that it is teaming up with...
Continuous glucose monitoring company Dexcom, which already allows users to monitor their CGM data on their phones and Apple Watch, is now making some patient data available to third parties via an API.
"If you look back at the past when our hardware was all proprietary, we’ve evolved from that to an app company where our CGM now works as an app on the phone," Dexcom CEO Kevin Sayer told...
In late 2014, MobiHealthNews reported that Atlanta-based diabetes management company Rimidi was piloting its software in a 129-patient RCT with Desert Oasis Healthcare, part of Heritage California ACO, a pioneer ACO. Now the company has made public some of the preliminary results from the ongoing study, showing that patients who used Rimidi’s intervention dropped their HbA1c by 2 percentage...
Atlanta, Georgia-based Cox Enterprises has invested in local company Rimidi, which has developed diabetes management and population health software.
Rimidi said it would use the funds to expand into other markets.
"We are thrilled to receive this investment from Cox Enterprises, a company that embraces innovation and collaboration and is helping shape the future of healthcare," Rimidi CEO ...
Atlanta-based rimidi is piloting its diabetes management and population health software Diabetes+Me in a 129-patient randomized control trial (RCT) with Heritage California ACO, a pioneer accountable care organization. The platform, which includes a mobile device-based patient engagement component, will be vetted for both its ability to lower A1C levels and for softer metrics like patient...
